Brickell Biotech, Inc. — Form D

Brickell Biotech, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-07. The offering totals $10, of which $10 was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2022-06-07
• Form: D
• Accession: 0000819050-22-000092
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $10
• Amount sold: $10
• Minimum investment: $10
• Investors: 1
• Date of first sale: 2022-05-25
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-448413

Issuer

• Name: Brickell Biotech, Inc.
• CIK: 0000819050
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 5777 CENTRAL AVENUE, BOULDER, CO, 80301
• Phone: (720) 505-4755

Officers, directors & promoters (12)

More

• CIK 819050 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search